Viridian Therapeutics
Waltham
About Viridian Therapeutics
Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $1.3B
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:VRDN
- Website: viridiantherapeutics.com
- Phone: +1 617 272 4600
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/viridian-therapeutics-46707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.